Clinical trial

A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004

NCT02042248

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-03-01

PhasePHASE1

Study timeline

Study start (unknown)2014-03-01Date precision: month

Registry last updated2017-05-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

AGS-004BIOLOGICAL

Sponsors & collaborators

Cynthia L Gay, MDlead sponsor

Argos Therapeuticscollaborator

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Mapped research locations

Chapel HillNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02042248 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.